AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-100 | >>

Table of contents of journal: *Molecular medicine today (Regular ed.)

Results: 26-50/784

Authors: Perks, B Rooke, K
Citation: B. Perks et K. Rooke, New resources on the web ..., MOL MED TOD, 6(7), 2000, pp. 260-260

Citation: Rapid update, MOL MED TOD, 6(7), 2000, pp. 260-260

Authors: Johnston, MI
Citation: Mi. Johnston, The role of nonhuman primate models in AIDS vaccine development, MOL MED TOD, 6(7), 2000, pp. 267-270

Authors: Jackson, PE Scholl, PF Groopman, JD
Citation: Pe. Jackson et al., Mass spectrometry for genotyping: an emerging tool for molecular medicine, MOL MED TOD, 6(7), 2000, pp. 271-276

Authors: Leventer, RJ Pilz, DT Matsumoto, N Ledbetter, DH Dobyns, WB
Citation: Rj. Leventer et al., Lissencephaly and subcortical band heterotopia: molecular basis and diagnosis, MOL MED TOD, 6(7), 2000, pp. 277-284

Authors: Mann, MJ
Citation: Mj. Mann, Gene therapy for peripheral arterial disease, MOL MED TOD, 6(7), 2000, pp. 285-291

Authors: Cohen, FE
Citation: Fe. Cohen, Prions, peptides and protein misfolding, MOL MED TOD, 6(7), 2000, pp. 292-293

Authors: Greener, M
Citation: M. Greener, Gene therapy trials face further scrutiny, MOL MED TOD, 6(6), 2000, pp. 211-211

Authors: Senior, K
Citation: K. Senior, Why genetic testing of adoptive children should be restricted, MOL MED TOD, 6(6), 2000, pp. 212-212

Authors: Dorrell, S
Citation: S. Dorrell, Better access to clinical trials information, MOL MED TOD, 6(6), 2000, pp. 213-213

Authors: Dorrell, S
Citation: S. Dorrell, Medicines from safer GMOs?, MOL MED TOD, 6(6), 2000, pp. 213-214

Authors: Habeck, M
Citation: M. Habeck, New approaches to treating haemophilia, MOL MED TOD, 6(6), 2000, pp. 214-215

Authors: Rooke, K
Citation: K. Rooke, Rapid update, MOL MED TOD, 6(6), 2000, pp. 215-215

Authors: Colbert, RA
Citation: Ra. Colbert, HLA-B27 misfolding: a solution to the spondyloarthropathy conundrum?, MOL MED TOD, 6(6), 2000, pp. 224-230

Authors: Dempsey, AA Ton, C Liew, CC
Citation: Aa. Dempsey et al., A cardiovascular EST repertoire: progress and promise for understanding cardiovascular disease, MOL MED TOD, 6(6), 2000, pp. 231-237

Authors: Turner, M Barnby, G Bailey, A
Citation: M. Turner et al., Genetic clues to the biological basis of autism, MOL MED TOD, 6(6), 2000, pp. 238-244

Authors: Chen, YT Amalfitano, A
Citation: Yt. Chen et A. Amalfitano, Towards a molecular therapy for glycogen storage disease type II (Pompe disease), MOL MED TOD, 6(6), 2000, pp. 245-251

Authors: McClatchey, AI
Citation: Ai. Mcclatchey, Neurofibromatosis type II: mouse models reveal broad roles in tumorigenesis and metastasis, MOL MED TOD, 6(6), 2000, pp. 252-253

Authors: Sansom, C
Citation: C. Sansom, Popping a pill to regulate therapeutic protein delivery, MOL MED TOD, 6(5), 2000, pp. 179-180

Authors: Habeck, M
Citation: M. Habeck, Pneumococci self-destruct, MOL MED TOD, 6(5), 2000, pp. 180-181

Authors: Fricker, J
Citation: J. Fricker, Engineered macrophages: a new weapon in the war on cancer?, MOL MED TOD, 6(5), 2000, pp. 181-182

Authors: Senior, K
Citation: K. Senior, Mitochondrial gene linked to rare hereditary tumour, MOL MED TOD, 6(5), 2000, pp. 183-183

Authors: Dorrell, S
Citation: S. Dorrell, Mucosal protection against HIV - a new role for IgG?, MOL MED TOD, 6(5), 2000, pp. 184-184

Authors: Cantu, JMC Figuera, LE
Citation: Jmc. Cantu et Le. Figuera, Virtual molecular medicine in developing countries: the Mexican initiative, MOL MED TOD, 6(5), 2000, pp. 190-192

Authors: Kooy, RF Willemsen, R Oostra, BA
Citation: Rf. Kooy et al., Fragile X syndrome at the turn of the century, MOL MED TOD, 6(5), 2000, pp. 193-198
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>